医药中间体是指在药物合成过程中作为关键步骤的反应产物或原料物质,它们通常是化学结构较为简单的化合物,通过一系列化学反应可以转化为最终的药物成品。这些中间体在制药工业中扮演着重要角色,是实现复杂药物分子合成的关键组成部分。
特点医药中间体的研发和生产是一个复杂的过程,通常包括以下几个步骤:
随着化学合成技术的进步和新技术的应用(如绿色化学、计算机辅助设计等),医药中间体的研发与生产正朝着更加高效、环保的方向发展。同时,对药物分子结构的深入理解也为开发更有效的治疗方案提供了更多可能性。
| 中文名称 | 英文名称 | CAS号 | 化学式 |
|---|---|---|---|
| 呋喃并[2,3-b]吡啶-3(2H)-酮 | furo[2,3-b]pyridin-3(2H)-one | 27038-48-8 | C7H5NO2 |
| 呋喃并[2,3-b]吡啶 | furo<2,3-b>pyridine | 272-01-5 | C7H5NO |
| 呋喃[3,2-b]吡啶-7-胺 | furo[3,2-b]pyridin-7-amine | 1186310-74-6 | C7H6N2O |
| 呋喃[2,3-C]并吡啶-2-甲醛 | furo<2,3-c>pyridine-2-carboxaldehyde | 112372-06-2 | C8H5NO2 |
| 呋喃-3-乙酸 | 2-(furan-3-yl)acetic acid | 123617-80-1 | C6H6O3 |
| 吲达帕胺杂质B | N-amino-2-methylindoline hydrochloride | 31529-47-2 | C9H12N2*ClH |
| 吲唑-5-甲酸甲酯 | methyl 1H-indazole-5-carboxylate | 473416-12-5 | C9H8N2O2 |
| 吲唑-3-乙酸 | 2-(1H-indazol-3-yl)acetic acid | 26663-42-3 | C9H8N2O2 |
| 吲哚酮-7-羧酸甲酯 | methyl oxindole-7-carboxylate | 380427-39-4 | C10H9NO3 |
| 吲哚酚 | indoxyl | 480-93-3 | C8H7NO |
| 吲哚美辛钠 | Indometacin (sodium hydrate) | 74252-25-8 | C19H21ClNNaO7 |
| 吲哚美辛杂质 | sodium 4-methoxybenzenediazosulfonate | 5354-81-4 | C7H7N2O4S*Na |
| 吲哚并[3,2-b]咔唑 | Indolo[3,2-b]carbazole | 241-55-4 | C18H10N2 |
| 吲哚并[3,2-b]咔唑 | 5H,11H-indolo[3,2-b]carbazole | 6336-32-9 | C18H12N2 |
| 吲哚并[3,2-B]咔唑-6-甲醛 | 6-Formylindolo-(3,2-b)-carbazole | 172922-91-7 | C19H12N2O |
| 吲哚并[3,2,1-jk]咔唑 | indolo[3,2,1-jk]carbazole | 205-95-8 | C18H11N |
| 吲哚并[2,3-C]咔唑 | 5,8-dihydro-indolo[2,3-C]carbazole | 200339-30-6 | C18H12N2 |
| 吲哚布芬杂质杂质10 | 2-(4-nitrophenyl)butanonitrile | 94814-82-1 | C10H10N2O2 |
| 吲哚布芬杂质19 | 2-(4-propylphenyl)isoindoline-1,3-dione | 19357-17-6 | C17H15NO2 |
| 吲哚布芬乙基乙酯杂质 | ethyl 2-(4-(1-oxoisoindolin-2-yl)phenyl)butanoate | 36691-02-8 | C20H21NO3 |
| 吲哚啉-7-甲醛 | indoline-7-carboxyaldehyde | 143262-21-9 | C9H9NO |
| 吲哚啉-5-羧酸甲酯 | methyl indoline-5-carboxylate | 141452-01-9 | C10H11NO2 |
| 吲哚啉-5-羧酸 | indoline-5-carboxylic acid | 15861-30-0 | C9H9NO2 |
| 吲哚啉-3-羧酸 | indoline-3-carboxylic acid | 39891-70-8 | C9H9NO2 |
| 吲哚啉 | 1-indoline | 496-15-1 | C8H9N |
| 吲哚[1,2-A]吡嗪 | imidazo[1,2-a]pyrazine | 274-79-3 | C6H5N3 |
| 吲哚-6-硼酸频哪醇酯 | 6-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)-1H-indole | 642494-36-8 | C14H18BNO2 |
| 吲哚-6-甲酸甲酯 | indole-6-carboxylic acid methyl ester | 50820-65-0 | C10H9NO2 |
| 吲哚-5-羧酸 | 1H-Indole-5-carboxylic acid | 1670-81-1 | C9H7NO2 |
| 吲哚-5-甲酸甲酯 | 5-methoxycarbonylindole | 1011-65-0 | C10H9NO2 |
| 吲哚-5-甲酸乙酯 | ethyl indole-5-carboxylate | 32996-16-0 | C11H11NO2 |
| 吲哚-4-羧酸甲酯 | methyl 1H-indole-4-carboxylate | 39830-66-5 | C10H9NO2 |
| 吲哚-4-羧酸 | 1H-indole-4-carboxylic acid | 2124-55-2 | C9H7NO2 |
| 吲哚-4-甲酸乙酯 | ethyl indole-4-carboxylate | 50614-84-1 | C11H11NO2 |
| 吲哚-3-醋酸乙酯 | ethyl 3-indoleacetate | 778-82-5 | C12H13NO2 |
| 吲哚-3-甲醇 | indole-3-carbinol | 700-06-1 | C9H9NO |
| 吲哚-3-乙醛酸甲酯 | 2-(3-indolyl)oxoacetic acid methyl ester | 18372-22-0 | C11H9NO3 |
| 吲哚-3-乙醛 | indole-3-acetaldehyde | 2591-98-2 | C10H9NO |
| 吲哚-3-乙酸钠 | sodium 2-(1H-indol-3-yl)ethanoate | 6505-45-9 | C10H8NO2*Na |
| 吲哚-2-羧酸甲酯 | indole-2-carboxylic acid methyl ester | 1202-04-6 | C10H9NO2 |
| 吲哚-2-羧酸乙酯 | 2-carbethoxyindole | 3770-50-1 | C11H11NO2 |
| 吲哚-2-羧酸 | Indole-2-carboxylic acid | 1477-50-5 | C9H7NO2 |
| 吩嗪-1-羧酸 | tubermycin B | 2538-68-3 | C13H8N2O2 |
| 吡罗克酮 | 6-(2,4,4-trimethylpentyl)-1-hydroxy-4-methyl-2(1H)-pyridone | 50650-76-5 | C14H23NO2 |
| 吡硫�f铜 | bis[1-hydroxypyridine-2(1H)-thionato-S,O]copper(II) | 14915-37-8 | C10H8CuN2O2S2 |
| 吡硫翁铜 | CopperPyrithione | 154592-20-8 | C10H10CuN2O2S2 |
| 吡托非农盐酸盐 | 2-[4-(2-piperidino-ethoxy)-benzoyl]-benzoic acid methyl ester; hydrochloride | 1248-42-6 | C22H25NO4*ClH |
| 吡嗪甲酸乙酯 | ethyl 2-pyrazinecarboxylate | 6924-68-1 | C7H8N2O2 |
| 吡嗪-2-羧酸甲酯 | methyl pyrazine-2-carboxylate | 6164-79-0 | C6H6N2O2 |
| 吡嗪-2-甲酰肼 | pyrazine-2-carbohydrazide | 768-05-8 | C5H6N4O |